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Background: Aortic valve diseases (AVD) are major public health burden. We hypothesized that due to availability of innovative treatment 
options the economic burden associated with AVD has grown considerably.
methods and results: With the use of Nationwide Inpatient Sample (NIS) from 2000-2012, AVD related hospitalizations were identified 
using ICD9 code 424.1 as the principal discharge diagnosis. Overall AVD hospitalizations increased by 59% from 2000-2012, particularly 
in patients >80 years old. Admissions for patients with higher comorbidities (Charlson comorbidity index (CCI) ≥2) doubled from 25% in 
2000 to 50% in 2012. The most frequent coexisting conditions in these patients were hypertension (58%) and heart failure (35.0%). Overall 
in-hospital mortality of patients hospitalized for AVD was 3.8% which has significantly declined from 4.5% in 2000 to 3.5% in 2012 (p2 
(58% reduction) and who were >80 years old (53% reduction). There was increase in disposition to another facility, 44.5% in 2000 to 60% 
in 2012 (p<0.001). There was a substantial increase in cost of hospitalization in the last decade from $31,909 to $38,172 (p<0.001). This 
represents an absolute increment in annual national cost from approximate 1.28 billion dollars in 2001 to 2.13 billion dollars in 2011.
conclusion:  The last decade has witnessed a significant decline in mortality with AVD hospitalizations in US. The associated increase in 
the cost hospitalization has considerably increased the economic burden of the disease. 
